Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 11/2019

01-11-2019 | Rectal Cancer | Special Section: Rectal Cancer

Locally recurrent rectal cancer: what the radiologist should know

Authors: Dhakshinamoorthy Ganeshan, Stephanie Nougaret, Elena Korngold, Gaiane M. Rauch, Courtney C. Moreno

Published in: Abdominal Radiology | Issue 11/2019

Login to get access

Abstract

Despite advances in surgical techniques and chemoradiation therapy, recurrent rectal cancer remains a cause of morbidity and mortality. After successful treatment of rectal cancer, patients are typically enrolled in a surveillance strategy that includes imaging as studies have shown improved prognosis when recurrent rectal cancer is detected during imaging surveillance versus based on development of symptoms. Additionally, patients who experience a complete clinical response with chemoradiation therapy may elect to enroll in a “watch-and-wait” strategy that includes imaging surveillance rather than surgical resection. Factors that increase the likelihood of recurrence, patterns of recurrence, and the imaging appearances of recurrent rectal cancer are reviewed with a focus on CT, PET CT, and MR imaging.
Literature
1.
Chioreso, C., et al., Association Between Hospital and Surgeon Volume and Rectal Cancer Surgery Outcomes in Patients With Rectal Cancer Treated Since 2000: Systematic Literature Review and Meta-analysis. Dis Colon Rectum, 2018. 61(11): p. 1320-1332.CrossRefPubMedPubMedCentral
2.
Ortholan, C., et al., Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials. Dis Colon Rectum, 2006. 49(3): p. 302-10CrossRefPubMed
3.
Heald, R.J. and R.D. Ryall, Recurrence and survival after total mesorectal excision for rectal cancer. Lancet, 1986. 1(8496): p. 1479-82.CrossRefPubMed
4.
Pollett, W.G. and R.J. Nicholls, The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg, 1983. 198(2): p. 159-63.CrossRefPubMedPubMedCentral
5.
Rasanen, M., et al., Pattern of rectal cancer recurrence after curative surgery. Int J Colorectal Dis, 2015. 30(6): p. 775-85.CrossRefPubMed
6.
van Gijn, W., et al., Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol, 2011. 12(6): p. 575-82.CrossRefPubMed
7.
Palmer, G., et al., A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol, 2007. 14(2): p. 447-54.CrossRefPubMed
8.
Zhao, J., et al., Patterns and prognosis of locally recurrent rectal cancer following multidisciplinary treatment. World J Gastroenterol, 2012. 18(47): p. 7015-20.CrossRefPubMedPubMedCentral
9.
Bird, T.G., et al., Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent. Int J Colorectal Dis, 2018. 33(4): p. 393-401.CrossRefPubMed
10.
Westberg, K., et al., Management and prognosis of locally recurrent rectal cancer - A national population-based study. Eur J Surg Oncol, 2018. 44(1): p. 100-107.CrossRefPubMed
11.
Harris, C.A., et al., The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer. Ann Surg, 2016. 264(2): p. 323-9.CrossRefPubMed
12.
Yamada, K., et al., Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg, 2001. 88(7): p. 988-93.CrossRefPubMed
13.
Lee, D.J., et al., Advances in surgical management for locally recurrent rectal cancer: How far have we come? World J Gastroenterol, 2017. 23(23): p. 4170-4180.CrossRefPubMedPubMedCentral
14.
Cai, Y., et al., Prognostic factors associated with locally recurrent rectal cancer following primary surgery (Review). Oncol Lett, 2014. 7(1): p. 10-16.CrossRefPubMed
15.
Zhang, X.Y., et al., MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology, 2018: p. 172889.
16.
Koca, D., et al., Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer. J BUON, 2012. 17(2): p. 291-8.PubMed
17.
Kusters, M., et al., Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol, 2010. 36(5): p. 470-6.CrossRefPubMed
18.
Leibold, T., et al., Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol, 2008. 26(13): p. 2106-11CrossRefPubMed
19.
20.
den Dulk, M., et al., Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg, 2007. 246(1): p. 83-90.CrossRef
21.
Lee, S.H., et al., The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Dis Colon Rectum, 2005. 48(12): p. 2249-57.CrossRefPubMed
22.
Chan, C.L., et al., Local recurrence after curative resection for rectal cancer is associated with anterior position of the tumour. Br J Surg, 2006. 93(1): p. 105-12.CrossRefPubMed
23.
Gunderson, L.L., et al., Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol, 2004. 22(10): p. 1785-96.CrossRefPubMed
24.
Compton, C.C., Pathologic prognostic factors in the recurrence of rectal cancer. Clin Colorectal Cancer, 2002. 2(3): p. 149-60.CrossRefPubMed
25.
Nagtegaal, I.D. and P. Quirke, What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol, 2008. 26(2): p. 303-12.CrossRefPubMed
26.
Nagtegaal, I.D., et al., Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol, 2002. 20(7): p. 1729-34.CrossRefPubMed
27.
Nagtegaal, I.D., et al., Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol, 2002. 26(3): p. 350-7.CrossRefPubMed
28.
Tural, D., et al., Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer. J BUON, 2013. 18(2): p. 385-90.PubMed
29.
De Caluwe, L., Y. Van Nieuwenhove, and W.P. Ceelen, Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev, 2013(2): p. CD006041.
30.
Fiorica, F., et al., Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data. Cancer Treat Rev, 2010. 36(7): p. 539-49.CrossRefPubMed
31.
Sebag-Montefiore, D., et al., Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet, 2009. 373(9666): p. 811-20.CrossRefPubMedPubMedCentral
32.
Wong, R.K., et al., Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev, 2007(2): p. CD002102.
33.
Camma, C., et al., Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA, 2000. 284(8): p. 1008-15.CrossRefPubMed
34.
Benson, A.B., 3rd, et al., Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2018. 16(7): p. 874-901.
35.
Folkesson, J., et al., Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol, 2005. 23(24): p. 5644-50.CrossRefPubMed
36.
Wang, X., et al., Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data. PLoS One, 2018. 13(7): p. e0200142.CrossRefPubMedPubMedCentral
37.
Zhou, Z.R., et al., Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis. Surg Oncol, 2014. 23(4): p. 211-21.CrossRefPubMed
38.
Leite, J.S., et al., Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer. Colorectal Dis, 2011. 13(4): p. 381-6.CrossRefPubMed
39.
Kitz, J., et al., Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. JAMA Surg, 2018. 153(8): p. e181607.CrossRefPubMedPubMedCentral
40.
Boras, Z., et al., Prognostic factors of local recurrence and survival after curative rectal cancer surgery: a single institution experience. Coll Antropol, 2012. 36(4): p. 1355-61.PubMed
41.
den Dulk, M., et al., The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer, 2009. 45(7): p. 1175-83.CrossRef
42.
Warschkow, R., et al., Survival after Abdominoperineal and Sphincter-Preserving Resection in Nonmetastatic Rectal Cancer: A Population-Based Time-Trend and Propensity Score-Matched SEER Analysis. Gastroenterol Res Pract, 2017. 2017: p. 6058907.CrossRefPubMedPubMedCentral
43.
Beyond, T.M.E.C., Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg, 2013. 100(8): p. E1-33.CrossRef
44.
Sammour, T. and G.J. Chang, Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: Mutually exclusive or mutually beneficial? Ann Gastroenterol Surg, 2018. 2(5): p. 348-350CrossRefPubMedPubMedCentral
45.
Ho, V.P., et al., Sexual function after treatment for rectal cancer: a review. Dis Colon Rectum, 2011. 54(1): p. 113-25.CrossRefPubMed
46.
Kusters, M., et al., A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg, 2009. 249(2): p. 229-35.CrossRefPubMed
47.
Lu, J.Y., et al., Comparison of Transanal Endoscopic Microsurgery and Total Mesorectal Excision in the Treatment of T1 Rectal Cancer: A Meta-Analysis. PLoS One, 2015. 10(10): p. e0141427.CrossRefPubMedPubMedCentral
48.
Kidane, B., et al., Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis. Dis Colon Rectum, 2015. 58(1): p. 122-40.CrossRefPubMed
49.
Sajid, M.S., et al., Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Colorectal Dis, 2014. 16(1): p. 2-14.CrossRefPubMed
50.
Nash, G.M., et al., Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum, 2009. 52(4): p. 577-82.CrossRefPubMed
51.
You, Y.N., et al., Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg, 2007. 245(5): p. 726-33.CrossRefPubMedPubMedCentral
52.
. Eriksen, M.T., et al., Inadvertent perforation during rectal cancer resection in Norway. Br J Surg, 2004. 91(2): p. 210-6.CrossRefPubMed
53.
Jorgren, F., et al., Oncological outcome after incidental perforation in radical rectal cancer surgery. Int J Colorectal Dis, 2010. 25(6): p. 731-40.CrossRefPubMed
54.
Ogura, A., et al., Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. J Clin Oncol, 2019. 37(1): p. 33-43.CrossRefPubMed
55.
Wang, S., et al., Adverse Effects of Anastomotic Leakage on Local Recurrence and Survival After Curative Anterior Resection for Rectal Cancer: A Systematic Review and Meta-analysis. World J Surg, 2017. 41(1): p. 277-284.CrossRefPubMed
56.
Uemura, M., et al., The features of late local recurrences following curative surgery for rectal cancer. Hepatogastroenterology, 2012. 59(118): p. 1800-3.PubMed
57.
Mirnezami, A.H. and P.M. Sagar, Surgery for recurrent rectal cancer: technical notes and management of complications. Tech Coloproctol, 2010. 14(3): p. 209-16.CrossRefPubMed
58.
Asoglu, O., et al., Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol, 2007. 33(10): p. 1199-206.CrossRefPubMed
59.
Wanebo, H.J., et al., Pelvic resection of recurrent rectal cancer. Ann Surg, 1994. 220(4): p. 586-95; discussion 595-7.
60.
Gunderson, L.L. and H. Sosin, Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer, 1974. 34(4): p. 1278-92.
61.
62.
Warrier, S.K., A.G. Heriot, and A.C. Lynch, Surgery for Locally Recurrent Rectal Cancer: Tips, Tricks, and Pitfalls. Clin Colon Rectal Surg, 2016. 29(2): p. 114-22.CrossRefPubMedPubMedCentral
63.
Enriquez-Navascues, J.M., et al., Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol, 2011. 17(13): p. 1674-84.CrossRefPubMedPubMedCentral
64.
Suzuki, K., et al., Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum, 1996. 39(7): p. 730-6.CrossRefPubMed
65.
Wanebo, H.J., et al., Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum, 1999. 42(11): p. 1438-48.CrossRefPubMed
66.
Moore, H.G., et al., Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum, 2004. 47(10): p. 1599-606.CrossRefPubMed
67.
Boyle, K.M., et al., Surgery for locally recurrent rectal cancer. Dis Colon Rectum, 2005. 48(5): p. 929-37.CrossRefPubMed
68.
Mohiuddin, M., et al., Curative surgical resection following reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys, 1997. 39(3): p. 643-9.CrossRefPubMed
69.
Sagar, P.M., Ultraradical resection for locally recurrent rectal cancer. Dis Colon Rectum, 2014. 57(1): p. 1-2.CrossRefPubMed
70.
Hartley, J.E., et al., Resection of locally recurrent colorectal cancer in the presence of distant metastases: can it be justified? Ann Surg Oncol, 2003. 10(3): p. 227-33.CrossRefPubMed
71.
Solomon, M.J., et al., Pubic Bone Excision and Perineal Urethrectomy for Radical Anterior Compartment Excision During Pelvic Exenteration. Dis Colon Rectum, 2015. 58(11): p. 1114-9.CrossRefPubMed
72.
Milne, T., et al., Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann Surg, 2013. 258(6): p. 1007-13.CrossRefPubMed
73.
Dozois, E.J., et al., High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved? J Surg Oncol, 2011. 103(2): p. 105-9.CrossRefPubMed
74.
Young, P.E., et al., Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges. J Cancer, 2014. 5(4): p. 262-71.CrossRefPubMedPubMedCentral
75.
Schaefer, O. and M. Langer, Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol, 2007. 17(8): p. 2044-54.CrossRefPubMed
76.
Rodriguez-Moranta, F., et al., Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol, 2006. 24(3): p. 386-93.CrossRefPubMed
77.
Chau, I., et al., The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol, 2004. 22(8): p. 1420-9.CrossRefPubMed
78.
Jeffery, M., et al., Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev, 2016. 11: p. CD002200.
79.
Mollica, M.A., et al., Examining colorectal cancer survivors’ surveillance patterns and experiences of care: a SEER-CAHPS study. Cancer Causes Control, 2017. 28(10): p. 1133-1141.CrossRefPubMed
80.
Kupfer, S.S., et al., Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated Comprehensive Cancer Centers. Cancer Med, 2018. 7(11): p. 5351-5358.CrossRefPubMedPubMedCentral
81.
Fichera, A., Less Is More in Colorectal Cancer Posttreatment Surveillance. JAMA Surg, 2018. 153(10): p. 877.CrossRefPubMed
82.
Snyder, R.A., et al., Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA, 2018. 319(20): p. 2104-2115.CrossRefPubMedPubMedCentral
83.
Rosati, G., et al., A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma. Ann Oncol, 2016. 27(2): p. 274-80.CrossRefPubMed
84.
Blomqvist, L., et al., MR imaging, CT and CEA scintigraphy in the diagnosis of local recurrence of rectal carcinoma. Acta Radiol, 1996. 37(5): p. 779-84.CrossRefPubMed
85.
Pema, P.J., et al., CT vs MRI in diagnosis of recurrent rectosigmoid carcinoma. J Comput Assist Tomogr, 1994. 18(2): p. 256-61.CrossRefPubMed
86.
Stueckle, C.A., et al., Multi-detector CT in the evaluation of patients with recurrence of rectal cancer. Technol Cancer Res Treat, 2006. 5(3): p. 285-9.CrossRefPubMed
87.
Even-Sapir, E., et al., Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology, 2004. 232(3): p. 815-22.CrossRefPubMed
88.
Maas, M., et al., What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for recurrent colorectal cancer. Eur J Nucl Med Mol Imaging, 2011. 38(8): p. 1560-71.CrossRefPubMedPubMedCentral
89.
Huebner, R.H., et al., A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med, 2000. 41(7): p. 1177-89.PubMed
90.
Kitajima, K., et al., Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging, 2009. 36(9): p. 1388-96.CrossRefPubMed
91.
Shamim, S.A., et al., Role of FDG-PET/CT in detection of recurrent disease in colorectal cancer. Nucl Med Commun, 2010. 31(6): p. 590-6.PubMed
92.
Berger, K.L., et al., FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol, 2000. 174(4): p. 1005-8.CrossRefPubMed
93.
Lee, D.H., et al., Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging. Radiology, 2016. 280(3): p. 782-92.CrossRefPubMed
94.
95.
Hupkens, B.J.P., et al., MRI surveillance for the detection of local recurrence in rectal cancer after transanal endoscopic microsurgery. Eur Radiol, 2017. 27(12): p. 4960-4969.CrossRefPubMed
96.
Torricelli, P., et al., Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Abdom Imaging, 2003. 28(1): p. 19-27.CrossRefPubMed
97.
Lambregts, D.M., et al., Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol, 2011. 21(6): p. 1250-8.CrossRefPubMedPubMedCentral
98.
Colosio, A., et al., Value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of pelvic recurrence from colorectal cancer. J Magn Reson Imaging, 2014. 40(2): p. 306-13.CrossRefPubMed
99.
Molinelli, V., et al., Role of MRI and added value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of local recurrence from rectal cancer. Abdom Radiol (NY), 2018. 43(11): p. 2903-2912.CrossRef
100.
Nural, M.S., et al., Efficiency of apparent diffusion coefficients in differentiation of colorectal tumor recurrences and posttherapeutical soft-tissue changes. Eur J Radiol, 2013. 82(10): p. 1702-9.CrossRefPubMed
101.
Robinson, P., et al., Recurrent or residual pelvic bowel cancer: accuracy of MRI local extent before salvage surgery. Clin Radiol, 2002. 57(6): p. 514-22.CrossRefPubMed
102.
Messiou, C., et al., Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol, 2008. 81(966): p. 468-73.CrossRefPubMed
103.
Brown, W.E., et al., Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer. Dis Colon Rectum, 2017. 60(2): p. 144-151.CrossRefPubMed
104.
Dresen, R.C., et al., Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology, 2010. 256(1): p. 143-50.CrossRefPubMed
105.
Habr-Gama, A., et al., Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg, 2004. 240(4): p. 711-7; discussion 717-8.
106.
Beets-Tan, R.G.H., et al., Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol, 2018. 28(4): p. 1465-1475.CrossRefPubMed
107.
Habr-Gama, A., et al., Alternative treatment to surgery for rectal cancer. Annals of Laparoscopic and Endoscopic Surgery, 2018. 3(5).
108.
Lambregts, D.M., et al., Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy. Dis Colon Rectum, 2011. 54(12): p. 1521-8.CrossRefPubMed
109.
Plodeck, V., et al., FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences. Eur Radiol, 2019. 29(1): p. 422-428.CrossRefPubMed
Metadata
Title
Locally recurrent rectal cancer: what the radiologist should know
Authors
Dhakshinamoorthy Ganeshan
Stephanie Nougaret
Elena Korngold
Gaiane M. Rauch
Courtney C. Moreno
Publication date
01-11-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02003-5

Other articles of this Issue 11/2019

Abdominal Radiology 11/2019 Go to the issue

Special Section: Rectal Cancer

Lymph node metastasis in rectal cancer: comparison of MDCT and MR imaging for diagnostic accuracy

Special Section: Rectal Cancer

Nodal drainage pathways in primary rectal cancer: anatomy of regional and distant nodal spread

Hollow Organ GI

MRI morphologic and clinicopathologic characteristics for predicting outcomes in patients with locally advanced rectal cancer

Special Section: Rectal Cancer

Pathologist’s perspective on primary rectal cancer

Special Section: Rectal Cancer

Primary and post-chemoradiotherapy staging using MRI in rectal cancer: the role of diffusion imaging in the assessment of perirectal infiltration

Editorial

Introduction to the special section on rectal cancer

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits